Replies to post #387130 on Anavex Life Sciences Corp (AVXL)

[chrismiss_everyday]

ANAVEX®2-73 treatment met the primary endpoints and reduced clinical decline on the global cognitive and functional scales over 48 weeks in the analysis of the Intent-to-treat (ITT) population.

Met primary AND secondary endpoints! And no brain bleeding.

[Mkc12five]

I dont know what Adam F is smoking! Its right there. Met Primary and key secondary end points. "Reversed cognitive decline". He is such a (insert @%!& here).